These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 17974726)
1. Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction. Jean-Philippe P; Freedman A; Chang MW; Steinberg SP; Gershon AA; LaRussa PS; Borkowsky W Pediatrics; 2007 Nov; 120(5):e1345-9. PubMed ID: 17974726 [TBL] [Abstract][Full Text] [Related]
2. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B; J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732 [TBL] [Abstract][Full Text] [Related]
3. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine. Watson B J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388 [TBL] [Abstract][Full Text] [Related]
4. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma. Bryan CJ; Prichard MN; Daily S; Jefferson G; Hartline C; Cassady KA; Hilliard L; Shimamura M Pediatr Infect Dis J; 2008 Oct; 27(10):946-8. PubMed ID: 18776818 [TBL] [Abstract][Full Text] [Related]
5. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. Levy O; Orange JS; Hibberd P; Steinberg S; LaRussa P; Weinberg A; Wilson SB; Shaulov A; Fleisher G; Geha RS; Bonilla FA; Exley M J Infect Dis; 2003 Oct; 188(7):948-53. PubMed ID: 14513412 [TBL] [Abstract][Full Text] [Related]
9. Reactogenicity and immunogenicity of a live-attenuated refrigerator-stable varicella vaccine (OKA strain) in healthy seronegative subjects age 10 months to 12 years. Hadinegoro SR; Hindra IS; Han HH; Gatchalian S; Bock HL Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):991-9. PubMed ID: 19842382 [TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
11. Generalized varicella in severe combined immunodeficiency with B lymphocytes. Timár L; Budai J; Szigeti R Acta Paediatr Acad Sci Hung; 1981; 22(4):353-7. PubMed ID: 6979157 [TBL] [Abstract][Full Text] [Related]
12. Determining the rate of varicella vaccine rash in children with moderate-severe eczema. Frydenberg AR; Buttery JP; Royle J J Paediatr Child Health; 2005 Nov; 41(11):561-3. PubMed ID: 16398837 [TBL] [Abstract][Full Text] [Related]
13. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child. Kramer JM; LaRussa P; Tsai WC; Carney P; Leber SM; Gahagan S; Steinberg S; Blackwood RA Pediatrics; 2001 Aug; 108(2):E39. PubMed ID: 11483849 [TBL] [Abstract][Full Text] [Related]
14. Secondary transmission of varicella vaccine virus in a chronic care facility for children. Grossberg R; Harpaz R; Rubtcova E; Loparev V; Seward JF; Schmid DS J Pediatr; 2006 Jun; 148(6):842-4. PubMed ID: 16769402 [TBL] [Abstract][Full Text] [Related]